Ibio Inc (NYSEAMERICAN:IBIO) was the recipient of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 61,565 shares, a decline of 78.6% from the October 13th total of 288,091 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average trading volume of 705,873 shares, the short-interest ratio is currently 0.1 days.

Ibio (NYSEAMERICAN:IBIO) traded down $0.01 during trading hours on Monday, hitting $0.28. The stock had a trading volume of 89,100 shares, compared to its average volume of 299,296. Ibio has a 52 week low of $0.26 and a 52 week high of $0.56.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/11/14/ibio-inc-ibio-short-interest-down-78-6-in-october.html.

Ibio Company Profile

iBio, Inc is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company’s technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants.

Receive News & Stock Ratings for Ibio Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ibio Inc and related stocks with our FREE daily email newsletter.